Back
Dianthus Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$56.87
Seasonality Move:
-9.72%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNTH is experiencing slight buying pressure.
Dianthus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.53 | Buy |
| 20-day SMA: | 50.82 | Buy |
| 50-day SMA: | 46.82 | Buy |
| 200-day SMA: | 33.1 | Buy |
| 8-day EMA: | 52.9 | Buy |
| 20-day EMA: | 51.04 | Buy |
| 50-day EMA: | 47.7 | Buy |
| 200-day EMA: | 36.87 | Buy |
Dianthus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 63.67 | Buy |
| Chaikin Money Flow: | 278132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.61 - 53.39) | Buy |
| Bollinger Bands (100): | (36.17 - 48.95) | Buy |
Dianthus Therapeutics, Inc. Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dianthus Therapeutics, Inc. Stock
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 55.26 while DNTH 8-day simple moving average is 52.53, which is a Buy signal.
-
The stock price of DNTH is 55.26 while Dianthus Therapeutics, Inc. 20-day SMA is 50.82, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day simple moving average is 46.82 while DNTH share price is 55.26, making it a Buy technically.
-
DNTH stock price is 55.26 and Dianthus Therapeutics, Inc. 200-day simple moving average is 33.10, creating a Buy signal.
DNTH Technical Analysis vs Fundamental Analysis
Buy
73
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. a Buy or a Sell?
-
Dianthus Therapeutics, Inc. stock is rated a BuyThe current Dianthus Therapeutics, Inc. [DNTH] share price is $55.26. The Score for DNTH is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Dianthus Therapeutics, Inc. Stock Info
Market Cap:
2.4B
Price in USD:
55.26
Share Volume:
614.8K
Dianthus Therapeutics, Inc. 52-Week Range
52-Week High:
57.50
52-Week Low:
13.37
Buy
73
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Dianthus Therapeutics, Inc. Share Price Forecast
-
What is the Dianthus Therapeutics, Inc. stock price today?The Dianthus Therapeutics, Inc. stock price is 55.26 USD today.
-
Will DNTH stock go up or go down?Dianthus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dianthus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dianthus Therapeutics, Inc. is not overvalued.
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 55.26 while DNTH 8-day exponential moving average is 52.90, which is a Buy signal.
-
The stock price of DNTH is 55.26 while Dianthus Therapeutics, Inc. 20-day EMA is 51.04, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day exponential moving average is 47.70 while DNTH share price is 55.26, making it a Buy technically.
-
DNTH stock price is 55.26 and Dianthus Therapeutics, Inc. 200-day simple moving average is 36.87, creating a Buy signal.
Fundamental Analysis of Dianthus Therapeutics, Inc.
Is Dianthus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and a decrease next year of $0.41 per share.
Technical Analysis of Dianthus Therapeutics, Inc.
Should I short Dianthus Therapeutics, Inc. stock?
-
DNTH Moving Average Covergence Divergence (MACD) indicator is 1.81, suggesting Dianthus Therapeutics, Inc. is a Buy
-
Dianthus Therapeutics, Inc. Relative Strength Index (RSI) is 63.67, which suggest Dianthus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Dianthus Therapeutics, Inc. is (48.61 - 53.39), which suggest Dianthus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Dianthus Therapeutics, Inc. is (36.17 - 48.95), which suggest Dianthus Therapeutics, Inc. is a Buy
* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.